You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Medical Dermatology Potpourri I

  • Authors: Hilary E. Baldwin, MD; Adam Friedman, MD; Julie C. Harper, MD; Robert G. Micheletti, MD; Linda F. Stein Gold, MD
  • CME / ABIM MOC / CE Released: 5/16/2022
  • Valid for credit through: 5/16/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.50 ABIM MOC points

    Nurses - 1.50 ANCC Contact Hour(s) (1.25 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians (PCPs), pediatricians, nurses, nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with dermatologic conditions.

The goal of this activity is to improve the management of patients with acne, rosacea, hidradenitis suppurative, or inflammatory skin disease.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • New and emerging evidence in topical acne treatments
    • Best practices for antibiotic use in the treatment of acne and rosacea
    • Current and emerging treatments for hidradenitis suppurativa
    • Individualized treatment based on patient characteristics such as age, gender, and Fitzpatrick skin type
  • Demonstrate greater confidence in their ability to
    • Manage patients affected by Hidradenitis suppurativa


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Hilary E. Baldwin, MD

    Clinical Associate Professor, Rutgers Robert Wood Johnson
    Medical Center
    Medical Director
    The Acne Treatment and Research Center
    New Brunswick, New Jersey

    Disclosures

    Disclosure: Hillary E. Baldwin, MD, has the following relevant financial relationships:
    Consultant or advisor for: Almirall; EPI; Galderma; La Roche Posay; Ortho; Sun; Vyne
    Speaker or member of speakers bureau for: Almirall; Galderma; La Roche Posay; Ortho; Sun

  • Adam Friedman, MD

    Professor and Chair
    Department of Dermatology
    George Washington School of Medicine and Health Sciences
    Washington, DC

    Disclosures

    Disclosure: Adam Friedman, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Aveeno; Brickell Biotech; Corbus; Dermira; FSD; Galderma; Hoth; Incyte; Insed; La Roche Posay; L'Oreal; Menlo; Mino; Microcures; Novartis; Pfizer; Regeneron; Sanofi; UCB; Zylo
    Speaker or member of speakers bureau for: AbbVie; Brickell Biotech; Incyte; Janssen; Regeneron; Sanofi
    Research funding from: Galderma; Incyte; Pfizer
    Patent beneficiary of: Microcures; Zylo
    Owns stock (privately owned) in: Microcures; Zylo

  • Julie C. Harper, MD

    Owner
    The Dermatology and Skin Care Center of Birmingham
    Birmingham, Alabama

    Disclosures

    Disclosure: Julie C. Harper, MD, has the following relevant financial relationships:
    Consultant or advisor for: Almirall; BioPharmX; Cassiopeia; Cutanea; Cutera; Dermira; EPI; La Roche Posay; Ortho; Sol Gel; Vyne
    Speaker or member of speakers bureau for: Almirall; Galderma; EPI; Ortho; Vyne

  • Robert G. Micheletti, MD

    Associate Professor of Dermatology and Medicine
    Chief of Hospital Dermatology
    Chief of Dermatology
    Pennsylvania Hospital
    Perelman School of Medicine
    University of Pennsylvania
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Robert G. Micheletti, MD, has the following relevant financial relationships:
    Consultant or advisor for: Adaptimmune; Vertex
    Research funding from: Amgen; Cabaletta; ChemoCentryx

  • Linda F. Stein Gold, MD

    Director of Dermatology Clinical Research
    Henry Ford Health System
    Detroit, Michigan

    Disclosures

    Disclosure: Linda F. Stein Gold, MD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Arcutis; Bristol Myers Squibb Company; Dermavant; EPI; Galderma; Incyte; Janssen; Ortho; Pfizer; Regeneron; Sanofi; UCB
    Speaker or member of speakers bureau for: AbbVie; Amgen; Incyte; Pfizer; Regeneron; Sanofi; Sun
    Research funding from: AbbVie; Amgen; Arcutis; Dermata; Dermavant; Galderma; Incyte; Ortho; Pfizer; UCB

Editors

  • Meghan Coulehan, MPH

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    Disclosure: Meghan Coulehan, MPH, has no relevant financial relationships.

  • Iwona Misiuta, PhD, MHA

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Iwona Misiuta, PhD, MHA, has no relevant financial relationships.

Compliance Reviewer

  • Esther Nyarko, PharmD

    Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has no relevant financial relationships.

Nurse Planner

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.25 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Medical Dermatology Potpourri I

Authors: Hilary E. Baldwin, MD; Adam Friedman, MD; Julie C. Harper, MD; Robert G. Micheletti, MD; Linda F. Stein Gold, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 5/16/2022

Valid for credit through: 5/16/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

What's New in Acne?

Do we need a revolution in topical retinoids?
Linda F. Stein Gold, MD

What's New in Rosacea?

Are you discussing rosacea as a comorbidity with your patients?
Hilary E. Baldwin, MD

Frenemies: Cutaneous Dysbiosis and Inflammatory Skin Diseases

Do you know how diverse microbiota help maintain a healthy skin barrier?
Adam Friedman, MD

What's New in Hidradenitis Suppurativa: Biologic and Small Molecule Therapies

Which therapies are supported by data for use in moderate to severe disease?
Robert G. Micheletti, MD

Women's Dermatologic Concerns

Is all acne hormonal?
Julie C. Harper, MD
 

Educational Impact Challenge

The goal of this activity is to improve the management of patients with acne, rosacea, hidradenitis suppurative, or inflammatory skin disease.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print